Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Aprovel 150mg Tablets - EU/1/97/046/022
- Calcium Acetate 500mg Tablets - PA0281/063/001
- Depo-Provera 150mg/ml Suspension for Injection - PA0822/124/001
- Innohep 3,500 IU, Solution for Injection - PA0046/060/009
- Lyrica 75mg Hard Capsules - EU/1/04/279/011-013
- Ondansetron 2mg/ml Solution for Injection or Infusion - PA0711/068/001
- Praxbind 50mcg/ml Solution for Injection/Infusion - EU/1/15/1056/001
- Prevymis 240mg Film Coated Tablets - EU/1/17/1245/001
- Visudyne 15mg Powder for Solution for Infusion - EU/1/00/140/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Cimeldine 400mg Film Coated Tablets - PA0126/077/002
- Kay-Cee-L Syrup 7.5% w/v - PA22637/004/001
- Pneumovax 23 Solution for Injection in Pre Filled Syringe - PA1286/055/002
- Propafenone hydrochloride 300mg Tablets - PA2315/116/002
- Rifinah 300mg/150mg Tablets - PA0540/068/002
- Sirdupla 25mcg/250mcg Per Metered Dose Pressurised Inhalation, Suspension - PA0577/201/002
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.